Development of TLR8 inhibitors for treatment of autoimmune diseases
Ended Project Grant Awarded Last action
- Award ID
- R43AI096641
- Recipient
-
Dynavax Technologies Corporation UEI JA7GSG397PL1
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $599,016
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Place of performance
- Berkeley, CA 94710, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $299,508 | |
| Amendment | $70,775 | |
| Original award | $228,733 |
Quick answers
Who received award R43AI096641?
R43AI096641 was awarded to Dynavax Technologies Corporation by National Institutes of Health (Department of Health and Human Services) on June 1, 2012.
How much is award R43AI096641 worth?
$599,016 has been obligated on R43AI096641.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award